Hu GM - Search Results

1

Optimised architecture-based grading system as an independent prognostic factor in resected lung adenocarcinoma.

Qiu JH, Hu GM, Zhang RZ, Hu M, Li Z, Zhang Y, Wu HF, Fu WJ, Zhang M, Feng YK, Niu L, Ren JL. Qiu JH, et al. Among authors: hu gm. J Clin Pathol. 2022 Mar;75(3):176-184. doi: 10.1136/jclinpath-2020-207104. Epub 2020 Dec 28. J Clin Pathol. 2022. PMID: 33372106

2

[Expression of CD10 in fibrous histiocytoma and its significance].

Hu GM, Chen HP, Wang CF, Wu HF, Feng YK, Ren JL. Hu GM, et al. Zhonghua Bing Li Xue Za Zhi. 2018 Feb 8;47(2):130-131. doi: 10.3760/cma.j.issn.0529-5807.2018.02.011. Zhonghua Bing Li Xue Za Zhi. 2018. PMID: 29429167 Chinese. No abstract available.

3

[Clinicopathologic features of gastric plexiform fibromyxoma].

Hu GM, Chen HP, Liu QY, Shi XC, Wu HF, Feng YK, Ren JL, Wang CF. Hu GM, et al. Zhonghua Bing Li Xue Za Zhi. 2018 Apr 8;47(4):258-262. doi: 10.3760/cma.j.issn.0529-5807.2018.04.006. Zhonghua Bing Li Xue Za Zhi. 2018. PMID: 29690664 Chinese.

4

[Gastrointestinal leiomyoma with interstitial cells of Cajal: mimicker of gastrointestinal stromal tumor].

Hu GM, Feng YK, Liu QY, Chen HP, Fu WJ, Zhang M, Chang J, Gu B, Wu HF, Ren JL. Hu GM, et al. Zhonghua Bing Li Xue Za Zhi. 2018 Jun 8;47(6):438-443. doi: 10.3760/cma.j.issn.0529-5807.2018.06.010. Zhonghua Bing Li Xue Za Zhi. 2018. PMID: 29886588 Chinese.

5

[The expression and significance of CD(276) and CD(133) in colorectal cancer and precancerous lesions].

Lu GF, Huang LN, Ren JL, Hu GM, Zheng ZH, Wu JX, Zhu YP, Tang FA. Lu GF, et al. Among authors: hu gm. Zhonghua Nei Ke Za Zhi. 2018 Jun 1;57(6):450-453. doi: 10.3760/cma.j.issn.0578-1426.2018.06.011. Zhonghua Nei Ke Za Zhi. 2018. PMID: 29925132 Chinese.

6

Clinical significance of the cribriform pattern in invasive adenocarcinoma of the lung.

Zhang R, Hu G, Qiu J, Wu H, Fu W, Feng Y, Zhang M, Chen C, Sun J, Zhang Y, Ren J. Zhang R, et al. J Clin Pathol. 2019 Oct;72(10):682-688. doi: 10.1136/jclinpath-2019-205883. Epub 2019 Jun 28. J Clin Pathol. 2019. PMID: 31253654

7

CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.

Hu M, Li Z, Qiu J, Zhang R, Feng J, Hu G, Ren J. Hu M, et al. Bioengineered. 2021 Dec;12(1):5996-6009. doi: 10.1080/21655979.2021.1972197. Bioengineered. 2021. PMID: 34494924 Free PMC article.

8

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.

Li Z, Hu M, Qiu J, Feng J, Zhang R, Wu H, Hu G, Ren J. Li Z, et al. Med Sci Monit. 2022 Jan 14;28:e933447. doi: 10.12659/MSM.933447. Med Sci Monit. 2022. PMID: 35027526 Free PMC article.

9

Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.

Feng J, Hu M, Li Z, Hu G, Han Y, Zhang Y, Zhang M, Ren J. Feng J, et al. Cells. 2022 Aug 22;11(16):2611. doi: 10.3390/cells11162611. Cells. 2022. PMID: 36010686 Free PMC article.

10

Upregulated expression of CD30 protein in sclerosing angiomatoid nodular transformation (SANT): studies of additional 4 cases and analyses of 6 cases previously published cases.

Zhou J, Zhang D, Hu G, Zheng X, Shen Q, Li W, Wang G, Ma Y, Xu J, Zhao Z. Zhou J, et al. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6064-9. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page